Ihp Therapeutics

Developer of a self-administered treatment for sickle cell disease vaso-occlusive crisis

placeSan Carlos, California, United States calendar_todayFounded 2020 language ihptherapeutics.com

Innovation

3 patent families — focus: Human necessities, Chemistry & metallurgy; filing pace steady. Cited 25 times.

YearFilings
20211
20233
20241
20252
20262

Investor mix

1 investor on record.

Investor typeCountShare
Other / undisclosed1100%
Coming soon